Free Trial
ASX:UBI

Universal Biosensors (UBI) Stock Price, News & Analysis

Universal Biosensors logo

About Universal Biosensors Stock (ASX:UBI)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
10,006 shs
Average Volume
N/A
Market Capitalization
A$22.36 million
P/E Ratio
N/A
Dividend Yield
8.55%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive UBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Universal Biosensors and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

UBI Stock News Headlines

A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.tc pixel
UBI Business School
See More Headlines

UBI Stock Analysis - Frequently Asked Questions

Universal Biosensors, Inc. (ASX:UBI) announced its earnings results on Tuesday, April, 30th. The company reported ($0.01) EPS for the quarter. Universal Biosensors had a negative trailing twelve-month return on equity of 59.40% and a negative net margin of 175.04%.

Company Calendar

Last Earnings
4/30/2019
Today
9/07/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:UBI
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$11.58 million
Net Margins
-175.04%
Pretax Margin
N/A
Return on Equity
-59.40%
Return on Assets
-27.91%

Debt

Debt-to-Equity Ratio
16.18
Current Ratio
5.03
Quick Ratio
2.13

Sales & Book Value

Annual Sales
A$7.13 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
1.26
Book Value
A$0.07 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
298,070,000
Free Float
N/A
Market Cap
A$22.36 million
Optionable
Not Optionable
Beta
0.93
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (ASX:UBI) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners